Feed Preview

Fast Growing

Tumor Vaccines

Tumor Vaccines diagram by Lightspring, Shutterstock
Lightspring, Shutterstock

Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. Discover the latest research on tumor vaccines here.

Top 20 most recent papers
Human Vaccines & Immunotherapeutics

Characterizing the vaccine knowledge, attitudes, beliefs, and intentions of pregnant women in Georgia and Colorado

Human Vaccines & ImmunotherapeuticsFebruary 21, 2020
Matthew Z DudleyDaniel A Salmon
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology

Leveraging Digital Data to Inform and Improve Quality Cancer Care

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive OncologyFebruary 19, 2020
Tina Hernandez-BoussardJames D Brooks
3
Journal of Acquired Immune Deficiency Syndromes : JAIDS

Human papillomavirus seroprevalence and seroconversion among men living with HIV: Cohort study in South Africa

Journal of Acquired Immune Deficiency Syndromes : JAIDSFebruary 22, 2020
Admire ChikandiwaSinead Delany-Moretlwe
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy

Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer ChemotherapyFebruary 23, 2020
Sabrina DallavalleRoberta Fruttero
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer

STING pathway expression identifies non-small cell lung cancers with an immune-responsive phenotype

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung CancerFebruary 19, 2020
Carminia M Della CorteLauren A Byers
2
PloS One

Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis

PloS OneFebruary 22, 2020
Verônica ColpaniEliana Márcia Wendland
Cancer Immunology, Immunotherapy : CII

miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy

Cancer Immunology, Immunotherapy : CIIFebruary 21, 2020
Meng ZhangWeiping Min
1
Nederlands tijdschrift voor geneeskunde

HPV vaccination with quadrivalent or nonavalent vaccine: an opportunity to eliminate genital warts as well

Nederlands tijdschrift voor geneeskundeFebruary 20, 2020
Jan E A M van Bergen
Biomolecules

Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement

BiomoleculesFebruary 22, 2020
Alexander Batista-DuharteSalvador Francisco Aliño
Nederlands tijdschrift voor geneeskunde

Continue to use the bivalent HPV vaccine; bivalent vaccine more effective than expected

Nederlands tijdschrift voor geneeskundeFebruary 20, 2020
Maarten J Postma, Jan C Wilschut
Urology

Detecting Invisible Bladder Cancers with Blue Light Cystoscopy

UrologyFebruary 23, 2020
Nima NassiriSiamak Daneshmand
Cancer Immunology, Immunotherapy : CII

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients

Cancer Immunology, Immunotherapy : CIIFebruary 21, 2020
Qian-Ting WangYou-Wen He
4
Frontiers in Pharmacology

Modeling HIV Pre-Exposure Prophylaxis

Frontiers in PharmacologyFebruary 22, 2020
Thomas StraubingerRobert Bies

See more papers from this feed

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.


Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Immuno-Oncology

Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Tumor Evasion of the Immune System

Tumor evasion of the immune system includes cells that operate their own growth and develop various strategies to escape from immune surveillance. Discover the latest research on tumor evasion of the immune system here.

© 2020 Meta ULC. All rights reserved
/feed-previews/tumor-vaccines/425c2067-dc8b-41cf-9a90-1df7c1b06dc1